crimeancongo
hemorrhag
fever
viru
cchfv
caus
mild
sever
hemorrhag
diseas
cchf
exclus
human
case
fatal
rate
present
efficaci
therapeut
option
control
clinic
trial
remain
unproven
support
care
remain
mainstay
treatment
cchf
endem
foci
present
wide
geograph
rang
includ
area
western
central
asia
middl
east
southeastern
europ
africa
cchfv
exist
enzoot
cycl
tick
mammal
geograph
distribut
viru
mirror
distribut
primari
tick
vector
speci
includ
member
hyalomma
genu
h
marginatum
h
anatolicum
h
truncatum
h
impeltatum
h
impressum
viral
transmiss
human
occur
via
tick
bite
via
exposur
bodi
fluid
virem
anim
human
follow
brief
incub
period
usual
day
cchfv
infect
initi
caus
nonspecif
symptom
includ
rapid
onset
highgrad
fever
fatigu
myalgia
frequent
accompani
vomit
diarrhea
progress
sever
diseas
character
thrombocytopenia
elev
circul
liver
enzym
hemorrhag
manifest
petechia
ecchymosi
epistaxi
well
gingiv
gastrointestin
cerebr
hemorrhag
sever
cchf
correl
increas
viral
load
dissemin
low
anticchfv
antibodi
titer
sever
thrombocytopenia
increas
clot
time
hemorrhag
high
level
proinflammatori
cytokin
eg
tumor
necrosi
factor
interleukin
elev
aspart
aminotransferas
alanin
aminotransferas
fatal
outcom
typic
result
dissemin
intravascular
coagulopathi
shock
andor
multiorgan
failur
cours
diseas
cchfv
wide
distribut
throughout
bodi
detect
spleen
lung
heart
intestin
tissu
fatal
human
case
main
cellular
target
infect
mononuclear
phagocyt
endotheli
cell
hepatocyt
infect
monocytederiv
macrophag
endotheli
cell
dendrit
cell
confirm
vitro
continu
research
cchf
develop
medic
countermeasur
need
base
sever
diseas
humantohuman
transmiss
absenc
vaccin
treatment
proven
efficaci
potenti
sever
outbreak
futur
although
research
cchfv
limit
signific
recent
advanc
cchfv
research
includ
modern
molecular
tool
vivo
diseas
model
offer
opportun
substanti
progress
field
develop
therapeut
vaccin
articl
summar
current
knowledg
cchfv
genom
replic
viral
protein
process
function
develop
revers
genet
system
also
highlight
area
import
futur
research
cchfv
member
genu
nairoviru
famili
bunyavirida
includ
five
genera
viru
speci
cchfv
character
tripartit
rna
genom
neg
polar
figur
tickborn
mainten
transmiss
complementari
noncod
region
ncr
present
termini
small
medium
larg
l
segment
cchfv
contribut
circular
appear
bunyaviru
genom
nine
termin
nucleotid
conserv
nairovirus
serv
viral
promot
region
ncr
necessari
viral
rnadepend
rna
polymeras
rdrp
l
protein
bind
initi
transcript
andor
replic
viral
genom
although
complet
ncr
sequenc
differ
viral
segment
capabl
initi
encapsid
transcript
replic
packag
genom
nascent
virion
recent
three
segment
cchfv
believ
encod
singl
protein
howev
second
protein
nonstructur
nss
encod
segment
opposit
orient
rel
nucleoprotein
np
gene
indic
cchfv
might
consid
ambisens
viru
figur
howev
ambisens
code
cchfv
involv
overlap
code
region
differ
ambisens
code
bunyavirus
arenavirus
viral
protein
encod
opposit
orient
separ
intergen
region
serv
transcript
termin
signal
contrast
segment
kb
compar
size
bunyavirus
kb
l
kb
segment
cchfv
significantli
larger
bunyavirus
contain
singl
gene
encod
glycoprotein
precursor
gpc
l
protein
respect
genom
segment
viral
rna
vrna
encapsid
np
l
protein
form
genom
ribonucleoprotein
complex
rnp
genom
rnp
packag
viral
particl
acquir
lipid
envelop
surfac
glycoprotein
gn
gc
figur
electron
microscopi
studi
nairovirus
report
spheric
particl
rel
uniform
size
diamet
nm
small
nm
spikelik
project
surfac
particl
character
precis
arrang
surfac
glycoprotein
requir
refin
method
cryoelectron
microscopi
initi
bind
cchfv
cell
surfac
mediat
glycoprotein
gn
andor
gc
howev
detail
specif
glycoprotein
involv
viral
attach
intern
fusion
remain
unknown
suspect
gc
respons
bind
cellular
receptor
monoclon
antibodi
target
gc
neutral
cchfv
infect
mammalian
cell
gc
cchfv
also
thought
mediat
fusion
predict
fusion
loop
cchfv
share
signific
homolog
rift
valley
fever
viru
rvfv
gc
fusion
loop
cellular
receptor
requir
cchfv
entri
identifi
function
interact
suggest
cchfv
gc
cell
surfac
nucleolin
protein
found
predominantli
within
nucleoli
nucleolin
serv
receptor
respiratori
syncyti
viru
function
entri
factor
japanes
enceph
viru
enhanc
entri
human
immunodefici
viru
hiv
howev
investig
context
cchfv
infect
need
support
involv
nucleolin
cchfv
cell
bind
andor
fusion
attach
cell
surfac
cchfv
endocytos
clathrinmedi
endocytosi
mechan
entri
requir
clathrin
clathrin
pit
adaptor
complex
cchfv
entri
also
depend
cholesterol
low
ph
follow
endocytosi
cchfv
particl
transport
earli
endosom
subsequ
multivesicular
bodi
mvb
process
depend
contrast
block
traffick
earli
endosom
late
endosom
transport
mvb
effect
infect
cchfv
associ
mvb
interf
format
function
mvb
exampl
deplet
compon
endosom
sort
complex
requir
transport
escrt
pathway
decreas
cchfv
infect
level
indic
mvb
like
main
organel
cchfv
envelop
fuse
host
membran
follow
cell
entri
fusion
genom
rnp
releas
cytosol
encapsid
vrna
serv
templat
l
protein
synthes
viral
mrna
figur
studi
describ
termini
nairoviru
mrna
element
involv
termin
transcript
howev
termin
region
dugb
viru
relat
nairoviru
contain
cap
sequenc
deriv
cellular
mrna
initi
viral
mrna
synthesi
l
protein
use
cap
primer
snatch
cellular
mrna
endonucleas
domain
locat
l
protein
cchfv
l
protein
contain
residu
predict
coordin
critic
cap
snatch
activ
demonstr
endonucleas
l
protein
mutat
select
abolish
l
protein
transcript
activ
impair
abil
replic
cchfv
genom
analogu
suggest
cap
primer
use
initi
cchfv
replic
replic
genom
rnp
process
requir
replic
encapsid
uncap
neg
sens
vrna
posit
sens
complementari
rna
crna
replic
rnp
minim
requir
l
protein
np
encapsid
form
crna
vrna
respect
defin
antigenom
genom
rnp
figur
sinc
cchfv
neg
strand
rna
viru
genom
rnp
use
templat
synthes
cap
mrna
produc
antigenom
rnp
replic
genom
rnp
crna
synthes
l
protein
np
subunit
ad
elong
strand
obtain
antigenom
rnp
turn
crna
antigenom
rnp
use
templat
obtain
genom
rnp
rnp
replic
follow
later
accompani
viral
protein
process
subsequ
matur
matur
cchfv
gpc
unusu
complex
share
littl
similar
glycoprotein
process
bunyavirus
gpc
matur
yield
structur
glycoprotein
gn
gc
secret
nonstructur
protein
nonstructur
protein
nsm
figur
nairovirus
bunyavirus
known
encod
secret
nonstructur
glycoprotein
yield
complet
set
glycoprotein
gpc
heavili
glycosyl
subsequ
cleav
host
proteas
includ
proprotein
convertas
famili
mammalian
serin
proteas
known
process
varieti
cellular
protein
viral
glycoprotein
bacteri
toxin
gpc
contain
ntermin
signal
peptid
direct
synthesi
secretori
pathway
upon
elong
transloc
endoplasm
reticulum
er
signal
peptid
remov
gpc
nglycosyl
fold
intramolecular
disulfid
bridg
form
transmembran
domain
precursor
protein
span
er
membran
five
time
gpc
complet
translat
cleav
gn
precursor
pregn
gc
precursor
pregc
nsm
step
thought
requir
signal
peptidas
intramembran
cleav
proteas
iclip
gener
three
protein
requir
cleavag
signal
peptid
near
within
transmembran
figur
product
matur
er
follow
pregn
pregc
transport
golgi
complex
pregn
mucinlik
domain
mld
acquir
numer
olink
glycan
pregn
traffic
golgi
complex
propos
site
cchfv
assembl
absenc
pregc
pregc
requir
pregn
exit
er
mutat
glycosyl
site
pregn
locat
matur
gn
region
block
pregn
exit
er
prevent
secret
suggest
critic
role
glycosyl
fold
normal
traffick
golgi
complex
limit
endoproteolysi
pregn
pregc
requir
complet
gpc
matur
host
proteas
requir
convert
pregc
gc
remain
unidentifi
given
pregc
cleavag
motif
cchfv
rkpl
ident
gpc
cleavag
motif
guanarito
viru
arenaviru
cleav
subtilisin
kexin
proteas
proteas
proteas
similar
specif
may
cleav
cchfv
pregc
cleavag
pregn
occur
earli
secretori
pathway
either
er
exit
cisgolgi
apparatu
pregn
cleavag
rrll
motif
liber
ntermin
product
contain
mld
domain
cleav
transgolgi
network
tgn
furin
wellconserv
rskr
motif
locat
junction
mld
domain
cleavag
predict
free
domain
mld
although
avail
antibodi
detect
uncleav
mldcontain
glycoprotein
cleav
mld
initi
specul
dimer
epitop
locat
within
mld
domain
present
glycoprotein
denatur
urea
reduc
agent
alter
mobil
addit
glycan
composit
nonstructur
glycoprotein
like
similar
base
compar
sensit
glycosidas
specif
n
olink
glycan
therefor
addit
experi
need
explain
differ
mobil
sdspage
understand
cchfv
assembl
egress
limit
like
bunyavirus
cchfv
rnp
like
found
cytoplasm
np
local
perinuclear
region
close
golgi
complex
subcellular
local
viral
glycoprotein
often
dictat
locat
viru
bud
accumul
glycoprotein
golgi
complex
tgn
np
perinuclear
region
compat
bud
assembl
cchfv
particl
golgi
complex
andor
tgn
follow
assembl
cchfv
particl
releas
exocytosi
often
absenc
discern
cytopatholog
egress
occur
basolater
membran
polar
epitheli
cell
primari
function
np
encapsid
vrna
crna
form
rnp
consist
role
rnp
format
np
shown
interact
n
ctermin
region
l
protein
coloc
tag
l
protein
transfect
cell
l
protein
antibodi
current
unavail
cchfv
prevent
studi
l
protein
infect
cell
cchfvinfect
cell
np
local
perinuclear
region
actin
filamentdepend
manner
interf
actin
polymer
reduc
cchfv
infect
np
like
perform
multipl
function
exampl
np
releas
cell
even
absenc
viral
particl
lead
format
spheric
particl
resembl
bunyavirus
suggest
possibl
role
viral
bud
import
insight
role
np
obtain
crystal
structur
cchfv
np
use
cchfv
isol
iraq
china
protein
structur
close
relat
np
arenavirus
np
bunyavirus
np
possess
two
major
domain
globular
head
flexibl
arm
arm
domain
protrud
globular
head
domain
cchfv
np
globular
head
domain
cchfv
np
compris
overal
structur
similar
np
lassa
viru
lasv
arenaviru
crystal
np
oligom
presenc
rna
demonstr
np
subunit
organ
headtotail
orient
arm
one
subunit
interact
head
domain
neighbor
subunit
assembl
doubl
antiparallel
superhel
polym
np
may
repres
organ
np
rnp
oligomer
appear
regul
np
function
absenc
rna
np
appear
exist
exclus
monom
state
np
bind
rna
weakli
suggest
np
oligom
effect
bind
rna
addit
compar
monomer
oligomer
np
organ
show
arm
domain
chang
conform
upon
oligomer
allow
stronger
bind
rna
natur
chemic
bond
rna
np
remain
unknown
rna
structur
yet
resolv
np
model
howev
mutat
three
cchfv
np
residu
predict
bind
rna
block
transcript
replic
cchfv
minigenom
np
may
contribut
viralmedi
immun
evas
multipl
aspect
mammalian
antivir
respons
appear
target
np
like
interferon
ifn
stimul
antivir
gene
mxa
inhibit
cchfv
replic
furthermor
np
highli
immunogen
major
target
b
cell
mammal
np
lasv
relat
hantavirus
shown
function
ifn
antagonist
howev
cchfv
np
suppress
ifn
respons
sendai
viru
infect
model
viru
strongli
activ
innat
immun
respons
doubl
strand
rna
dsrna
structur
relat
arenaviru
np
possess
conserv
exonucleas
activ
specif
rna
rnase
activ
suppress
innat
immun
respons
dsrna
vitro
cchfv
np
endonucleas
activ
appear
restrict
dna
instead
rna
earli
infect
cchfv
inhibit
apoptosi
later
infect
induc
apoptosi
apotosi
fraction
np
cleav
put
devd
motif
locat
apex
arm
domain
sinc
arm
domain
interact
head
domain
np
oligom
steric
hindranc
associ
np
oligomer
would
prevent
cleavag
np
np
monom
may
prevent
apoptosi
act
decoy
substrat
delay
apoptosi
suggest
structur
relat
arenaviru
viru
transfect
cell
recent
describ
cchfv
nss
local
mitochondria
induc
apoptosi
disrupt
mitochondri
membran
potenti
although
nss
detect
cchfvinfect
cell
propos
apoptot
function
base
exclus
overexpress
nss
investig
nss
warrant
overal
cchfv
glycoprotein
appear
involv
entri
fusion
virion
format
immun
evas
gn
gc
believ
mediat
entri
fusion
function
part
extrapol
glycoprotein
distantli
relat
bunyavirus
cytoplasm
tail
gn
contain
zinc
finger
domain
bind
rna
vitro
suggest
gn
may
interact
rna
perform
matrix
proteinlik
function
howev
rna
encapsid
rnp
clear
gn
might
bind
incorpor
rnp
nascent
virion
function
studi
cchfv
gpc
highlight
essenti
role
pregn
convertas
product
infecti
particl
importantli
pregn
pregc
normal
local
golgi
complex
impli
correct
process
protein
regul
product
infecti
cchfv
particl
determin
function
particularli
intrigu
nairovirusspecif
share
sequenc
homolog
cellular
viral
protein
furin
cleavag
shown
select
block
product
without
affect
secret
cleavag
product
block
furin
cleavag
result
transient
reduct
viral
titer
impli
matur
import
cchfv
replic
least
cell
cultur
addit
block
furin
cleavag
also
result
slight
reduct
pregn
process
show
furin
cleavag
might
indirectli
regul
gpc
process
mld
found
pregn
interestingli
glycoprotein
precursor
filovirus
eg
ebola
viru
marburg
viru
also
contain
mld
furin
cleavag
site
filovirus
furin
cleavag
product
structur
compon
virion
olink
glycan
mld
shield
protect
epitop
target
neutral
antibodi
ebola
viru
mld
replac
cchfv
mld
without
affect
protein
function
suggest
mld
cchfv
may
also
shield
expos
epitop
howev
function
cchfv
mld
may
differ
significantli
filovirus
cchfv
mld
incorpor
viral
particl
addit
truncat
cchfv
mld
dispens
fold
traffick
gpc
contrast
longer
ntermin
truncat
compris
domain
retain
gn
er
suggest
domain
chaperon
activ
assist
pregn
fold
free
er
nairovirus
unusu
larg
l
protein
amino
acid
compar
famili
bunyavirida
member
amino
acid
addit
sequenc
present
ntermin
region
nairoviru
l
protein
found
bunyavirida
genom
find
suggest
amino
acid
may
contain
domain
nonclass
l
function
ovarian
tumor
otu
cystein
proteas
sequenc
locat
otu
domain
rdrp
conserv
motif
contain
potenti
leucin
zipper
zinc
finger
motif
import
bind
np
ntermin
region
l
protein
figur
l
protein
region
involv
mrna
transcript
replic
viral
genom
like
start
intern
endonucleas
domain
includ
sever
conserv
rdrp
motif
viral
endonucleas
cleav
host
mrna
use
result
cap
oligonucleotid
primer
initi
viral
transcript
termini
cchfv
vrna
monophosphoryl
contrast
mani
rna
virus
use
common
triphosph
group
monophosphoryl
genom
end
like
creat
chain
initi
mechan
call
prime
realign
viral
endonucleas
gener
cleav
first
nucleotid
genom
end
mechan
previous
suggest
relat
hantaan
viru
process
cchfv
genom
termini
monophosph
group
possibl
strategi
evad
innat
immun
respons
blunt
activ
retino
acidinduc
gene
rigi
preferenti
activ
nevertheless
typei
ifn
respons
cchfv
requir
rigi
rigi
believ
function
sensor
viral
infect
also
antivir
effector
effector
function
may
partial
explain
rna
virus
induc
poor
ifn
respons
prefer
rigi
ligand
replic
effici
rigi
knock
extens
studi
region
cchf
l
protein
ntermin
otu
domain
residu
otu
domain
remov
ubiquitin
ub
ublik
protein
ifnstimul
protein
substrat
viral
otu
papainlik
proteas
similar
activ
previous
found
posit
negativestrand
rna
virus
includ
dugb
viru
nairobi
sheep
diseas
viru
rice
stripe
viru
porcin
reproduct
respiratori
syndrom
viru
equin
arter
viru
murin
hepat
viru
sever
acut
respiratori
syndrom
coronaviru
human
coronaviru
middl
east
respiratori
syndrom
coronaviru
addit
deubiquitinas
positivestrand
rna
virus
proteolyt
process
viral
polyprotein
therefor
necessari
replic
cchfv
l
protein
proteolyt
process
otu
domain
otu
cystein
proteas
activ
dispens
cchfv
transcript
replic
minigenom
mammalian
deubiquitinas
implic
neg
feedback
system
ifn
respons
viral
otu
appear
perform
similar
function
cchfv
otu
domain
thought
suppress
innat
immun
signal
deconjug
ub
conjug
ub
ubiquitin
isgyl
lysin
residu
regul
ifn
signal
target
sever
key
compon
innat
immun
respons
includ
nuclear
factor
kappalightchainenhanc
activ
b
cell
rigi
mxa
interferon
regulatori
factor
signal
transduc
activ
transcript
protein
kinas
r
pkr
crystal
structur
cchfv
otu
domain
provid
insight
ub
bind
specif
allow
design
cchfv
mutant
specif
lack
activ
ub
overexpress
cchfv
otu
domain
result
reduc
gener
cellular
ubiquitin
isgyl
level
addit
cchfv
otu
overexpress
reduc
rigimitochondri
antiviralsign
protein
mav
mediat
ifnrespons
like
overexpress
block
ubiquitin
rigi
put
role
otu
infect
remain
paradox
ubiquitin
rigi
tripartit
motifcontain
protein
activ
wherea
isgyl
rigi
neg
regul
rigi
activ
compet
ubiquitin
site
studi
requir
understand
deubiquitin
rigi
viral
otu
may
facilit
viral
replic
simultan
remov
moieti
rigi
may
also
result
increas
antivir
respons
minigenom
system
use
studi
viral
transcript
replic
encapsid
use
model
rna
instead
fulllength
vrna
crna
use
genom
antigenom
analogu
call
minigenom
minigenom
contain
termin
ncr
genom
segment
cchfv
code
region
replac
report
gene
sinc
minigenom
system
noninfecti
use
full
cchfv
genom
allow
studi
cchfv
outsid
high
biocontain
laboratori
minigenom
system
dna
copi
vrna
minigenom
clone
express
vector
control
promot
cotransfect
plasmid
yield
minigenom
rna
figur
revers
genet
system
reli
promot
express
singl
termin
g
ad
rna
termini
enhanc
activ
nativ
terminu
gener
use
hepat
delta
viru
ribozym
np
l
protein
provid
either
express
plasmid
superinfect
cchfv
minigenom
rna
encapsid
act
templat
replic
transcript
result
product
mrna
ultim
report
signal
report
signal
provid
quantit
collect
measur
genom
replic
transcript
translat
howev
use
l
protein
mutat
catalyt
possibl
monitor
replic
alon
mutant
unabl
transcrib
mrna
due
lack
cap
snatch
activ
highli
use
cchfv
minigenom
system
limit
model
aspect
viral
replic
use
studi
process
requir
glycoprotein
entri
viru
assembl
egress
order
overcom
limit
inher
minigenom
system
entri
compet
viruslik
particl
vlp
system
also
develop
vlp
contain
viral
protein
minigenom
therefor
unabl
express
viral
protein
upon
enter
target
cell
particl
system
mimic
singlecycl
infect
encod
cchfv
protein
system
studi
outsid
high
biocontain
laboratori
vlp
gener
express
three
helper
plasmid
encod
np
gpc
l
protein
togeth
minigenom
plasmid
result
incorpor
encapsid
minigenom
rna
vlp
figur
vlp
abl
enter
target
cell
rnp
serv
templat
replic
transcript
cchfv
np
l
protein
suppli
tran
date
two
differ
cchfv
vlp
system
develop
first
system
transcript
compet
vlp
tcvlp
incub
target
cell
express
cchfv
np
l
protein
order
obtain
robust
renilla
report
activ
use
studi
cell
entri
second
system
transcript
entri
compet
vlp
tecvlp
gener
use
codonoptim
version
l
protein
gpc
nanoluc
report
produc
vlp
result
tecvlp
enter
target
cell
gener
robust
nanoluc
signal
without
need
express
l
protein
np
target
cell
simplifi
workflow
studi
entri
primari
transcript
figur
cchfv
infecti
clone
system
allow
product
infecti
recombin
cchfv
rcchfv
dna
plasmid
contain
complet
genom
sequenc
control
promot
success
rescu
rcchfv
requir
addit
helper
plasmid
transfect
cell
rcchfv
rescu
process
three
plasmid
contain
full
sequenc
one
genom
segment
transfect
permiss
cell
eg
genom
transcrib
crna
copi
figur
use
replic
templat
vrna
helper
plasmid
design
produc
np
l
protein
provid
tran
synthes
encapsid
vrna
final
product
reconstitut
genom
rnp
genom
rnp
obtain
replic
transcript
driven
np
l
protein
produc
viral
mrna
product
viral
protein
np
gpc
l
protein
ultim
assembl
rcchfv
particl
capabl
infect
neighbor
cell
perform
multipl
infect
cycl
sinc
rcchfv
infecti
precaut
biosafeti
level
restrict
associ
live
cchfv
experiment
must
adher
key
success
system
codon
optim
dna
sequenc
l
helper
plasmid
codon
optim
l
protein
increas
activ
amount
fulllength
l
protein
present
transfect
cell
infecti
clone
system
comprehens
model
avail
viru
replic
cycl
newli
gener
rcchfv
must
function
perform
basic
step
viral
replic
cycl
success
rescu
viru
mutat
abolish
protein
function
critic
replic
prohibit
viru
rescu
without
insight
specif
aspect
replic
cycl
disrupt
minigenom
vlp
system
use
precis
dissect
effect
mutat
treatment
individu
step
viral
replic
cycl
cchf
medic
import
tickborn
diseas
wide
endem
distribut
present
antivir
strategi
treat
human
cchfv
infect
remain
controversi
experiment
wide
use
antivir
ribavirin
shown
effect
cchfv
vitro
anim
model
clinic
benefit
remain
unproven
although
signific
advanc
made
field
recent
year
mani
aspect
cchfv
replic
cycl
pathogenesi
still
remain
poorli
defin
addit
studi
improv
knowledg
viral
protein
warrant
structur
andor
sequenc
similar
cchfv
np
np
relat
betterstudi
arenavirus
may
help
predict
put
function
cchfv
np
domain
guid
futur
research
advent
advanc
molecular
tool
studi
np
context
viral
infect
potenti
greatli
enhanc
understand
role
np
potenti
differ
variou
cchfv
genotyp
addit
studi
cchfv
glycoprotein
function
critic
area
research
due
signific
gap
knowledg
essenti
role
glycoprotein
viral
replic
cycl
improv
knowledg
glycoprotein
process
may
provid
target
develop
medic
countermeasur
sinc
furin
rel
minor
role
cchfv
replic
cycl
compar
pharmacolog
inhibitor
may
repres
promis
drug
target
efficaci
studi
proprotein
convertas
inhibitor
vivo
vitro
critic
need
better
assess
therapeut
potenti
furin
inhibit
develop
understand
otu
domain
provid
key
inform
cchfvmediat
innat
immun
modul
otudefect
inact
mutant
may
potenti
vaccin
candid
revers
genet
use
investig
cchfv
otu
mutant
select
cleav
ub
conjug
shed
light
specif
role
conjug
play
cchfv
infect
futur
experi
focu
investig
otu
function
context
viru
infect
previou
experi
overexpress
cchfv
otu
domain
provid
valuabl
insight
function
may
accur
reflect
event
natur
infect
factor
like
spatiotempor
distribut
may
affect
fulllength
l
protein
otu
domain
activ
advanc
aforement
area
complement
support
addit
investig
viral
interact
tickvector
host
studi
molecular
aspect
cchfv
replic
almost
exclus
focus
cell
cultur
system
mammalian
cell
sinc
cchfv
establish
persist
infect
tick
cchfv
replic
viral
protein
function
studi
tick
tick
cell
line
addit
research
involv
tick
vector
vector
deriv
cell
may
aid
elucid
aspect
cchfv
remain
unclear
tradit
mammalian
cell
base
studi
exist
receptor
ifnar
mous
model
cchf
use
screen
efficaci
antivir
experiment
vaccin
develop
exist
diseas
model
studi
cchfvinfect
cell
indic
import
earli
innat
immun
respons
diseas
order
better
model
earli
event
human
infect
continu
effort
made
develop
immunocompet
cchf
anim
model
immunocompet
model
may
provid
critic
insight
correl
protect
enhanc
understand
molecular
mechan
underli
pathogenesi
larg
restrict
vitro
investig
time
given
complex
role
immun
respons
cchf
pathogenesi
model
would
invalu
screen
new
therapeut
vaccin
candid
cchfv
recogn
signific
emerg
public
health
threat
becom
higher
public
health
prioriti
vaccin
therapeut
develop
cchf
rapidli
expand
field
howev
summari
field
beyond
scope
review
review
recent
vitro
experiment
research
effort
aim
elucid
mechan
cchfv
replic
pathogenesi
provid
comprehens
summari
known
aspect
cchfv
replic
cycl
viral
protein
function
cellmedi
host
respons
infect
also
identifi
area
cchfv
research
remain
unknown
unclear
merit
addit
investig
